Product Information
FULPHILA 6 MG/0.6 ML SYRINGE is a brand biologic product labeled by Biocon Biologics Inc., priced at $3369.5100 per ML under NDC 83257000541. Its NADAC has been published 46 times since Nov 19, 2025.
Strength
6 mg/.6mL
Manufacturer
Biocon Biologics Inc.NDC
83257000541
Classification
Brand Biologic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
PEGFILGRASTIMApproval Type
Biologic (BLA)
FDA Application
BLA761075On Market Since
10/1/2023
Pharmacological Classes
Price Statistics
The NADAC for FULPHILA 6 MG/0.6 ML SYRINGE has been published 46 times since Nov 19, 2025, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3369.5100 per ML |
|---|---|
| All-time high | $3369.5100 (Sep 30, 2026) |
| All-time low | $3182.3467 (Nov 19, 2025) |
| 52-week high | $3369.5100 |
| 52-week low | $3182.3467 |
| Median price | $3185.9367 |
| Average price | $3193.6059 |
| Largest weekly change | +5.8% (Sep 23, 2026) |
| Weeks tracked | 46 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pegfilgrastim-jmdb market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Biologics Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pegfilgrastim-jmdb market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Leukocyte Growth Factor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FULPHILA 6 MG/0.6 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for FULPHILA 6 MG/0.6 ML SYRINGE, manufactured by Biocon Biologics Inc., is $3369.5100 per ML (NDC 83257000541), effective Sep 30, 2026.
How has the price of FULPHILA 6 MG/0.6 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for FULPHILA 6 MG/0.6 ML SYRINGE has risen 5.9%. It has been tracked across 46 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for FULPHILA 6 MG/0.6 ML SYRINGE?
Since Nov 19, 2025, the NADAC for FULPHILA 6 MG/0.6 ML SYRINGE has ranged from a low of $3182.3467 (Nov 19, 2025) to a high of $3369.5100 (Sep 30, 2026), with a median of $3185.9367 per ML.
Are there cheaper alternatives to FULPHILA 6 MG/0.6 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient and strength of FULPHILA 6 MG/0.6 ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FULPHILA 6 MG/0.6 ML SYRINGE?
FULPHILA 6 MG/0.6 ML SYRINGE (NDC 83257000541) is labeled by Biocon Biologics Inc., and CMS classifies it as a brand biologic product.